USFDA issues warning letter to Indoco Remedies’ Goa plantPost published:April 12, 2017Post category:Industry NewsUSFDA inspectors found significant violations of manufacturing practice regulations for finished pharmaceuticals at Indoco Remedies after inspecting it last year Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostCarlsberg India launches new beer Tuborg Classic Next PostApple’s Make in India tax demands rejected due to GST, says minister You Might Also Like Game4Automation introduces 3D CAD drawings for virtual commissioning July 31, 2019 GKN to Open Global Technology Center in Bristol, UK January 17, 2019 China’s Midea Group to invest Rs800 crore for a manufacturing plant in Maharashtra June 29, 2017